{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447986588
| IUPAC_name = 4-(3-oxobutyl)-1,2-di(phenyl)pyrazolidine-3,5-dione
| image = Kebuzone.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 853-34-9
| ATC_prefix = M01
| ATC_suffix = AA06
| PubChem = 3824
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 3692
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB08940 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4VD83UL6Y6
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01567
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 31749

<!--Chemical data-->
| C=19 | H=18 | N=2 | O=3 
| molecular_weight = 322.35782 g/mol
|  smiles = CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C19H18N2O3/c1-14(22)12-13-17-18(23)20(15-8-4-2-5-9-15)21(19(17)24)16-10-6-3-7-11-16/h2-11,17H,12-13H2,1H3
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = LGYTZKPVOAIUKX-UHFFFAOYSA-N
}}

'''Kebuzone''' (or '''ketophenylbutazone''') is a [[nonsteroidal anti-inflammatory drug]] (NSAID).

==References==
{{Reflist|2}}


{{Anti-inflammatory and antirheumatic products}}

[[Category:Ketones]]
[[Category:Pyrazolidindiones]]


{{musculoskeletal-drug-stub}}